Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide in early onset preeclampsia
NCT03419364Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Nov 2017
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide in preeclampsia, sponsored by University of North Carolina at Chapel Hill. Started Nov 2017; status: completed.
02
Drugs
nicotinamide
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03419364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03419364.